Bachem - Public Comps and Valuation Multiples

Bachem Overview

About Bachem

Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and USA. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.

Founded

1971

HQ

Employees

2.2K+

Website

bachem.com

Sectors

Chemicals
Biopharmaceuticals
BioTech

Financials

LTM Revenue $832M

LTM EBITDA $237M

EV

$5.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Bachem Financials

As of September 2025, Bachem reported last 12-month revenue of $832M and EBITDA of $237M.

In the same period, Bachem generated $247M in LTM gross profit and $146M in net income.

See Bachem valuation multiples based on analyst estimates

Bachem P&L

In the most recent fiscal year, Bachem reported revenue of $752M and EBITDA of $222M.

Bachem expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Bachem valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$832M	XXX	$752M	XXX	XXX	XXX
Gross Profit	$247M	XXX	$227M	XXX	XXX	XXX
Gross Margin	30%	XXX	30%	XXX	XXX	XXX
EBITDA	$237M	XXX	$222M	XXX	XXX	XXX
EBITDA Margin	29%	XXX	29%	XXX	XXX	XXX
EBIT	$177M	XXX	$165M	XXX	XXX	XXX
EBIT Margin	21%	XXX	22%	XXX	XXX	XXX
Net Profit	$146M	XXX	$149M	XXX	XXX	XXX
Net Margin	17%	XXX	20%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Bachem including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $832M. EBITDA for the last twelve months was $237M. In the most recent fiscal year, Bachem achieved $752M in revenue and $222M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$832M	Analyst estimates available to subscribers	$752M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$247M	Analyst estimates available to subscribers	$227M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	29.6% gross margin	Analyst estimates available to subscribers	30.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$237M	Analyst estimates available to subscribers	$222M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	28.6% EBITDA margin	Analyst estimates available to subscribers	29.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$177M	Analyst estimates available to subscribers	$165M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	21.3% EBIT margin	Analyst estimates available to subscribers	22.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$146M	Analyst estimates available to subscribers	$149M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	17.5% net profit margin	Analyst estimates available to subscribers	19.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Bachem

This financial data table provides comprehensive performance metrics for Bachem, a company based in Switzerland. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Bachem generated $832M in revenue over the last twelve months.
The company achieved $237M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $247M.
Net income over the last twelve months reached $146M.

Fiscal Year Performance

In the most recent fiscal year, Bachem reported $752M in total revenue.
Fiscal year EBITDA was $222M.
The company maintained a gross profit margin of 30.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 29.5%.
Net profit margin reached 19.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Bachem. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Bachem Stock Performance

Bachem has current market cap of CHF 4.1B (or $5.1B), and EV of CHF 4.0B (or $5.0B).

Market Cap Evolution

Bachem Stock Data

As of October 17, 2025, Bachem's stock price is CHF 55 (or $68).

See Bachem trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.0B	$5.1B	XXX	XXX	XXX	XXX	$1.99

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Bachem Valuation Multiples

Bachem's trades at 6.6x EV/Revenue multiple, and 22.5x EV/EBITDA.

See valuation multiples for Bachem and 15K+ public comps

Bachem Financial Valuation Multiples

As of October 17, 2025, Bachem has market cap of $5.1B and EV of $5.0B.

Equity research analysts estimate Bachem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bachem has a P/E ratio of 35.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$5.1B	XXX	$5.1B	XXX	XXX	XXX
EV (current)	$5.0B	XXX	$5.0B	XXX	XXX	XXX
EV/Revenue	6.0x	XXX	6.6x	XXX	XXX	XXX
EV/EBITDA	21.0x	XXX	22.5x	XXX	XXX	XXX
EV/EBIT	28.2x	XXX	30.2x	XXX	XXX	XXX
EV/Gross Profit	20.2x	XXX	n/a	XXX	XXX	XXX
P/E	35.1x	XXX	34.2x	XXX	XXX	XXX
EV/FCF	-21.9x	XXX	-29.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Bachem Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Bachem Margins & Growth Rates

Bachem's last 12 month revenue growth is 35%

Bachem's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $28K for the same period.

Bachem's rule of 40 is 64% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bachem's rule of X is 115% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Bachem and other 15K+ public comps

Bachem Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	35%	XXX	26%	XXX	XXX	XXX
EBITDA Margin	29%	XXX	29%	XXX	XXX	XXX
EBITDA Growth	41%	XXX	7%	XXX	XXX	XXX
Rule of 40	64%	XXX	64%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	115%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$28K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	3%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	8%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial